Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling mtor signaling'

Search results for: 'research area pi3k akt signaling mtor signaling'

Items 31-40 of 44

Page
per page
  1. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL
  2. CZC24832
    A3340 CZC24832
    Summary: Selective PI3K-γ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.07 mg/mL
  3. BAY 80-6946 (Copanlisib)
    B2178 BAY 80-6946 (Copanlisib)
     1 Citation
    Target: PI3K
    Summary: PI3K inhibitor
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  4. PIK-293
    B2187 PIK-293
    Summary: PI3K inhibitor
      Soluble in DMSO
  5. TG100713
    B2177 TG100713
    Target: PI3K
    Summary: pan-PI3K inhibitor
      soluble in DMSO
  6. LY3023414
    B6099 LY3023414
    Target: Akt|PI3K|mTOR|DNA-PK
    Summary: class I PI3K isoforms, mTOR and DNA-PK inhibitor
      ≥40.6 mg/mL
  7. PX 866
    C3271 PX 866
    Summary: PI3K inhibitor
      ≤25 mg/mL
  8. CAY10505
    B2182 CAY10505
    Summary: Potent PI3Kγ inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.45 mg/mL
  9. HS-173
    B4492 HS-173
    Target: PI3K
    Summary: novel PI3K inhibitor
      ≥21.1 mg/mL
  10. PF-4989216
    B5948 PF-4989216
    Summary: Selective oral PI3K inhibitor
      Soluble in DMSO

Items 31-40 of 44

Page
per page